“Smart” Immune Cells: Emerging Cancer Therapy Research at UC Davis Boosted with NIH Award

By David Slipher

Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics in the UC Davis College of Biological Sciences, has received a $1.5 million award from the National Institutes of Health to advance the development of “smart” immune cells for therapies to treat cancer and other diseases. The five-year NIH Director’s New Innovator Award aims to provide new insight into how to engineer immune cells to control their recruitment and response to tumors.

Sean Collins

Assistant professor Sean Collins has received a NIH New Innovator award for work to make cancer therapies safer. Fred Greaves, UC Davis